SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 46 filers reported holding SATSUMA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $8,788,000 | -33.9% | 1,885,939 | 0.0% | 0.09% | -8.4% |
Q2 2021 | $13,296,000 | +19.3% | 1,885,939 | 0.0% | 0.10% | -26.9% |
Q1 2021 | $11,146,000 | +28.2% | 1,885,939 | 0.0% | 0.13% | +35.4% |
Q4 2020 | $8,694,000 | +18.5% | 1,885,939 | 0.0% | 0.10% | -26.7% |
Q3 2020 | $7,336,000 | -86.5% | 1,885,939 | 0.0% | 0.13% | -86.3% |
Q2 2020 | $54,240,000 | +33.6% | 1,885,939 | 0.0% | 0.96% | +2.5% |
Q1 2020 | $40,585,000 | +9.3% | 1,885,939 | 0.0% | 0.94% | +70.9% |
Q4 2019 | $37,115,000 | -34.4% | 1,885,939 | -50.0% | 0.55% | +30.9% |
Q3 2019 | $56,616,000 | – | 3,771,878 | – | 0.42% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 3,118,761 | $14,533,000 | 3.83% |
Ghost Tree Capital, LLC | 904,225 | $4,214,000 | 1.23% |
RA Capital Management | 5,914,252 | $27,560,000 | 0.38% |
Vivo Capital, LLC | 1,232,394 | $5,743,000 | 0.26% |
Nan Fung Group Holdings Ltd | 142,900 | $666,000 | 0.21% |
Ikarian Capital, LLC | 629,384 | $2,934,000 | 0.21% |
NEA Management Company, LLC | 3,142,958 | $14,646,000 | 0.17% |
SAMLYN CAPITAL, LLC | 1,716,067 | $7,998,000 | 0.11% |
TPG Group Holdings (SBS) Advisors, Inc. | 1,885,939 | $8,788,000 | 0.09% |
GSA CAPITAL PARTNERS LLP | 90,665 | $422,000 | 0.04% |